The Trendlines Group is an investment firm that focuses on early-stage investments in medical and agricultural technologies, providing capital and guidance to bring innovations to market. Recently, the firm has shifted its strategy to prioritize developing its existing portfolio companies to maximize exit proceeds, temporarily suspending new investments.
50% of their portfolio is in Healthcare. Their most common stage is seed (75% of deals). Average disclosed round size is $3.2M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Arcuro Medical | Series A | — | Jan 2025 |
| FFruitSpec | Seed | $5M | Dec 2021 |
 Fidmi Medical Ltd. | Seed | $2.2M | Oct 2021 |
 BioFishency Ltd. | Seed | $2.4M | Mar 2019 |
Top Co-Investors
Last updated: 10 April 2026